There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract.
Significance: Measurement and imaging of hemoglobin oxygenation are used extensively in the detection
and diagnosis of disease; however, the applied instruments vary widely in their depth
of imaging, spatiotemporal resolution, sensitivity, accuracy, complexity, physical
size, and cost. The wide variation in available instrumentation can make it challenging
for end users to select the appropriate tools for their application and to understand
the relative limitations of different methods.
Aim: We aim to provide a systematic overview of the field of hemoglobin imaging and sensing.
Approach: We reviewed the sensing and imaging methods used to analyze hemoglobin oxygenation,
including pulse oximetry, spectral reflectance imaging, diffuse optical imaging, spectroscopic
optical coherence tomography, photoacoustic imaging, and diffuse correlation spectroscopy.
Results: We compared and contrasted the ability of different methods to determine hemoglobin
biomarkers such as oxygenation while considering factors that influence their practical
application.
Conclusions: We highlight key limitations in the current state-of-the-art and make suggestions
for routes to advance the clinical use and interpretation of hemoglobin oxygenation
information.
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015. Methods We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures. Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60 900 unique data sources. Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013. For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data. For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores. Findings We generated 9·3 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year. In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17·2 billion, 95% uncertainty interval [UI] 15·4–19·2 billion) and diarrhoeal diseases (2·39 billion, 2·30–2·50 billion). Eight causes of chronic disease and injury each affected more than 10% of the world's population in 2015: permanent caries, tension-type headache, iron-deficiency anaemia, age-related and other hearing loss, migraine, genital herpes, refraction and accommodation disorders, and ascariasis. The impairment that affected the greatest number of people in 2015 was anaemia, with 2·36 billion (2·35–2·37 billion) individuals affected. The second and third leading impairments by number of individuals affected were hearing loss and vision loss, respectively. Between 2005 and 2015, there was little change in the leading causes of years lived with disability (YLDs) on a global basis. NCDs accounted for 18 of the leading 20 causes of age-standardised YLDs on a global scale. Where rates were decreasing, the rate of decrease for YLDs was slower than that of years of life lost (YLLs) for nearly every cause included in our analysis. For low SDI geographies, Group 1 causes typically accounted for 20–30% of total disability, largely attributable to nutritional deficiencies, malaria, neglected tropical diseases, HIV/AIDS, and tuberculosis. Lower back and neck pain was the leading global cause of disability in 2015 in most countries. The leading cause was sense organ disorders in 22 countries in Asia and Africa and one in central Latin America; diabetes in four countries in Oceania; HIV/AIDS in three southern sub-Saharan African countries; collective violence and legal intervention in two north African and Middle Eastern countries; iron-deficiency anaemia in Somalia and Venezuela; depression in Uganda; onchoceriasis in Liberia; and other neglected tropical diseases in the Democratic Republic of the Congo. Interpretation Ageing of the world's population is increasing the number of people living with sequelae of diseases and injuries. Shifts in the epidemiological profile driven by socioeconomic change also contribute to the continued increase in years lived with disability (YLDs) as well as the rate of increase in YLDs. Despite limitations imposed by gaps in data availability and the variable quality of the data available, the standardised and comprehensive approach of the GBD study provides opportunities to examine broad trends, compare those trends between countries or subnational geographies, benchmark against locations at similar stages of development, and gauge the strength or weakness of the estimates available. Funding Bill & Melinda Gates Foundation.
Published by SPIE under a Creative Commons Attribution 4.0 International License.
Distribution or reproduction of this work in whole or in part requires full attribution
of the original publication, including its DOI.
History
Date
received
: 6
April
2022
Date
accepted
: 27
June
2022
Page count
Figures: 6,
Tables: 1,
References: 267,
Pages: 32
Funding
Funded by: General Sir John Monash Foundation
Funded by: Cancer Research UK
Award ID: C9545/A29580
Funded by: EPSRC
Award ID: EP/R003599/1
Funded by: GAPSTI
Categories
Subject:
Review Papers
Subject:
Paper
Custom metadata
running-head Taylor-Williams et al.: Noninvasive hemoglobin sensing and imaging: optical tools
for disease diagnosis
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Smart Citations